trial · primary record
DS-3939a
Solid Tumor
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 400 |
| Primary completion | 2032-01-29 |
| Primary endpoint | Part 1: Number of Participants With Dose-limiting Toxicities (DLTs) |
| Registry ID | NCT07739966 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:55.065Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07739966
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.